Vector Manufacturing
Source: Cell & Gene
In this segment, Cartesian Therapeutics SVP and head of manufacturing operations, Emily English, Ph.D., explains the company’s unique mRNA-based approach to CAR-T manufacturing. The panelists also discuss how vector supply can impact CAR-T production.
        access the Video!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
            
        
        
            Case Studies & White Papers
            
        
        
            Extensive Product Database
            
        
        
            Members-Only Premium Content
            
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
        Subscribe to Cell & Gene
        X
    
    
        Subscribe to Cell & Gene